Technical Data
S9500-36A
Synuclein, alpha 2 (SNCA, 127750, P37840, MGC110988, NACP, PARK1, PARK4, non-A beta Component of AD Amyloid, NACP, Parkinson Disease Familial 1, PD1)
Description:
Applications:
Suitable for use in ELISA, Western Blot. Other applications not tested.

Recommended Dilution:
Western Blot: 1:1000-1:5000 for neat serum and 1-10ug/ml for affinity pure using ECL.
ELISA: 1:10,000-1:100,000 using 50-100ng of control peptide/well.
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O or PBS. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
100ul-20CBlue IceRatRabbit
Concentration:
As reported
Immunogen:
19 aa peptide locating near the C-terminus of rat synuclein-alpha, form 2
Purity:
Affinity purified over control-peptide Sepharose
Form
Supplied as a lyophilized powder from PBS, 0.05% sodium azide.
Specificity:
The rat peptide sequence is only found in rat-synuclein-alpha form 2. Therefore antibody will not detect Form 1 and 2. It has no appreciable homology with synuclein-beta or other proteins. The appropriate control immunogenic peptides are also available to confirm specificity of antibodies.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Jakes et al (1994) FEBS Lett. 345, 27-32; Ueda K et al (1993) PNAS 0, 11282-11286; Maroteaux L. et al (1988) J Neurosci. 8, 2804-2815; Maroteaux L et al (1991) Mol. Brain Res. 11, 335-343